Medical Care
Global CXO Services Market Research Report 2025
- Jul 08, 25
- ID: 347043
- Pages: 132
- Figures: 140
- Views: 2
The global market for CXO Services was valued at US$ 79400 million in the year 2024 and is projected to reach a revised size of US$ 161597 million by 2031, growing at a CAGR of 10.9% during the forecast period.
CXO Services refer to a broad category of outsourced services provided to pharmaceutical, biotechnology, and life sciences companies to support the development, manufacturing, and commercialization of drugs and therapeutics. The term "CXO" collectively represents contract-based services, in this report, CXO include CRO and CDMO.
North American market for CXO Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for CXO Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for CXO Services in Pharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of CXO Services include Lonza, Catalent, Samsung Biologics, FUJIFILM Diosynth Biotechnologies, Boehringer Ingelheim, Wuxi AppTec, Charles River, Labcorp, Eurofins Scientific, PPD, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CXO Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CXO Services.
The CXO Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CXO Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CXO Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Catalent
Samsung Biologics
FUJIFILM Diosynth Biotechnologies
Boehringer Ingelheim
Wuxi AppTec
Charles River
Labcorp
Eurofins Scientific
PPD, Inc.
ICON Plc.
Pharmaron
Recipharm
Thermo Fisher Scientific
AGC Biologics
Rentschler Biopharma
KBI Biopharma
Siegfried
Aenova Group
GenScript
ProBioGen
Northway Biotech
3P Biopharmaceuticals
Inotiv
ChemPartner
JOINN Lab
EVOTEC
Medicilon
Crown Bioscience
Champion Oncology
IQVIA
Parexel
Syneos Health
PRA Health Sciences
Medpace Holdings
Tigermed
Boji Medical Technology
Segment by Type
CRO
CDMO
Segment by Application
Pharmaceutical Companies
Medical Device Companies
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CXO Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
CXO Services refer to a broad category of outsourced services provided to pharmaceutical, biotechnology, and life sciences companies to support the development, manufacturing, and commercialization of drugs and therapeutics. The term "CXO" collectively represents contract-based services, in this report, CXO include CRO and CDMO.
North American market for CXO Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for CXO Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for CXO Services in Pharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of CXO Services include Lonza, Catalent, Samsung Biologics, FUJIFILM Diosynth Biotechnologies, Boehringer Ingelheim, Wuxi AppTec, Charles River, Labcorp, Eurofins Scientific, PPD, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CXO Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CXO Services.
The CXO Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CXO Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CXO Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Catalent
Samsung Biologics
FUJIFILM Diosynth Biotechnologies
Boehringer Ingelheim
Wuxi AppTec
Charles River
Labcorp
Eurofins Scientific
PPD, Inc.
ICON Plc.
Pharmaron
Recipharm
Thermo Fisher Scientific
AGC Biologics
Rentschler Biopharma
KBI Biopharma
Siegfried
Aenova Group
GenScript
ProBioGen
Northway Biotech
3P Biopharmaceuticals
Inotiv
ChemPartner
JOINN Lab
EVOTEC
Medicilon
Crown Bioscience
Champion Oncology
IQVIA
Parexel
Syneos Health
PRA Health Sciences
Medpace Holdings
Tigermed
Boji Medical Technology
Segment by Type
CRO
CDMO
Segment by Application
Pharmaceutical Companies
Medical Device Companies
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CXO Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CXO Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 CRO
1.2.3 CDMO
1.3 Market by Application
1.3.1 Global CXO Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Companies
1.3.3 Medical Device Companies
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CXO Services Market Perspective (2020-2031)
2.2 Global CXO Services Growth Trends by Region
2.2.1 Global CXO Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CXO Services Historic Market Size by Region (2020-2025)
2.2.3 CXO Services Forecasted Market Size by Region (2026-2031)
2.3 CXO Services Market Dynamics
2.3.1 CXO Services Industry Trends
2.3.2 CXO Services Market Drivers
2.3.3 CXO Services Market Challenges
2.3.4 CXO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CXO Services Players by Revenue
3.1.1 Global Top CXO Services Players by Revenue (2020-2025)
3.1.2 Global CXO Services Revenue Market Share by Players (2020-2025)
3.2 Global Top CXO Services Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CXO Services Revenue
3.4 Global CXO Services Market Concentration Ratio
3.4.1 Global CXO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CXO Services Revenue in 2024
3.5 Global Key Players of CXO Services Head office and Area Served
3.6 Global Key Players of CXO Services, Product and Application
3.7 Global Key Players of CXO Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CXO Services Breakdown Data by Type
4.1 Global CXO Services Historic Market Size by Type (2020-2025)
4.2 Global CXO Services Forecasted Market Size by Type (2026-2031)
5 CXO Services Breakdown Data by Application
5.1 Global CXO Services Historic Market Size by Application (2020-2025)
5.2 Global CXO Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CXO Services Market Size (2020-2031)
6.2 North America CXO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CXO Services Market Size by Country (2020-2025)
6.4 North America CXO Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CXO Services Market Size (2020-2031)
7.2 Europe CXO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CXO Services Market Size by Country (2020-2025)
7.4 Europe CXO Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific CXO Services Market Size (2020-2031)
8.2 Asia-Pacific CXO Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CXO Services Market Size by Region (2020-2025)
8.4 Asia-Pacific CXO Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America CXO Services Market Size (2020-2031)
9.2 Latin America CXO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CXO Services Market Size by Country (2020-2025)
9.4 Latin America CXO Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CXO Services Market Size (2020-2031)
10.2 Middle East & Africa CXO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CXO Services Market Size by Country (2020-2025)
10.4 Middle East & Africa CXO Services Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza CXO Services Introduction
11.1.4 Lonza Revenue in CXO Services Business (2020-2025)
11.1.5 Lonza Recent Development
11.2 Catalent
11.2.1 Catalent Company Details
11.2.2 Catalent Business Overview
11.2.3 Catalent CXO Services Introduction
11.2.4 Catalent Revenue in CXO Services Business (2020-2025)
11.2.5 Catalent Recent Development
11.3 Samsung Biologics
11.3.1 Samsung Biologics Company Details
11.3.2 Samsung Biologics Business Overview
11.3.3 Samsung Biologics CXO Services Introduction
11.3.4 Samsung Biologics Revenue in CXO Services Business (2020-2025)
11.3.5 Samsung Biologics Recent Development
11.4 FUJIFILM Diosynth Biotechnologies
11.4.1 FUJIFILM Diosynth Biotechnologies Company Details
11.4.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.4.3 FUJIFILM Diosynth Biotechnologies CXO Services Introduction
11.4.4 FUJIFILM Diosynth Biotechnologies Revenue in CXO Services Business (2020-2025)
11.4.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim CXO Services Introduction
11.5.4 Boehringer Ingelheim Revenue in CXO Services Business (2020-2025)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Wuxi AppTec
11.6.1 Wuxi AppTec Company Details
11.6.2 Wuxi AppTec Business Overview
11.6.3 Wuxi AppTec CXO Services Introduction
11.6.4 Wuxi AppTec Revenue in CXO Services Business (2020-2025)
11.6.5 Wuxi AppTec Recent Development
11.7 Charles River
11.7.1 Charles River Company Details
11.7.2 Charles River Business Overview
11.7.3 Charles River CXO Services Introduction
11.7.4 Charles River Revenue in CXO Services Business (2020-2025)
11.7.5 Charles River Recent Development
11.8 Labcorp
11.8.1 Labcorp Company Details
11.8.2 Labcorp Business Overview
11.8.3 Labcorp CXO Services Introduction
11.8.4 Labcorp Revenue in CXO Services Business (2020-2025)
11.8.5 Labcorp Recent Development
11.9 Eurofins Scientific
11.9.1 Eurofins Scientific Company Details
11.9.2 Eurofins Scientific Business Overview
11.9.3 Eurofins Scientific CXO Services Introduction
11.9.4 Eurofins Scientific Revenue in CXO Services Business (2020-2025)
11.9.5 Eurofins Scientific Recent Development
11.10 PPD, Inc.
11.10.1 PPD, Inc. Company Details
11.10.2 PPD, Inc. Business Overview
11.10.3 PPD, Inc. CXO Services Introduction
11.10.4 PPD, Inc. Revenue in CXO Services Business (2020-2025)
11.10.5 PPD, Inc. Recent Development
11.11 ICON Plc.
11.11.1 ICON Plc. Company Details
11.11.2 ICON Plc. Business Overview
11.11.3 ICON Plc. CXO Services Introduction
11.11.4 ICON Plc. Revenue in CXO Services Business (2020-2025)
11.11.5 ICON Plc. Recent Development
11.12 Pharmaron
11.12.1 Pharmaron Company Details
11.12.2 Pharmaron Business Overview
11.12.3 Pharmaron CXO Services Introduction
11.12.4 Pharmaron Revenue in CXO Services Business (2020-2025)
11.12.5 Pharmaron Recent Development
11.13 Recipharm
11.13.1 Recipharm Company Details
11.13.2 Recipharm Business Overview
11.13.3 Recipharm CXO Services Introduction
11.13.4 Recipharm Revenue in CXO Services Business (2020-2025)
11.13.5 Recipharm Recent Development
11.14 Thermo Fisher Scientific
11.14.1 Thermo Fisher Scientific Company Details
11.14.2 Thermo Fisher Scientific Business Overview
11.14.3 Thermo Fisher Scientific CXO Services Introduction
11.14.4 Thermo Fisher Scientific Revenue in CXO Services Business (2020-2025)
11.14.5 Thermo Fisher Scientific Recent Development
11.15 AGC Biologics
11.15.1 AGC Biologics Company Details
11.15.2 AGC Biologics Business Overview
11.15.3 AGC Biologics CXO Services Introduction
11.15.4 AGC Biologics Revenue in CXO Services Business (2020-2025)
11.15.5 AGC Biologics Recent Development
11.16 Rentschler Biopharma
11.16.1 Rentschler Biopharma Company Details
11.16.2 Rentschler Biopharma Business Overview
11.16.3 Rentschler Biopharma CXO Services Introduction
11.16.4 Rentschler Biopharma Revenue in CXO Services Business (2020-2025)
11.16.5 Rentschler Biopharma Recent Development
11.17 KBI Biopharma
11.17.1 KBI Biopharma Company Details
11.17.2 KBI Biopharma Business Overview
11.17.3 KBI Biopharma CXO Services Introduction
11.17.4 KBI Biopharma Revenue in CXO Services Business (2020-2025)
11.17.5 KBI Biopharma Recent Development
11.18 Siegfried
11.18.1 Siegfried Company Details
11.18.2 Siegfried Business Overview
11.18.3 Siegfried CXO Services Introduction
11.18.4 Siegfried Revenue in CXO Services Business (2020-2025)
11.18.5 Siegfried Recent Development
11.19 Aenova Group
11.19.1 Aenova Group Company Details
11.19.2 Aenova Group Business Overview
11.19.3 Aenova Group CXO Services Introduction
11.19.4 Aenova Group Revenue in CXO Services Business (2020-2025)
11.19.5 Aenova Group Recent Development
11.20 GenScript
11.20.1 GenScript Company Details
11.20.2 GenScript Business Overview
11.20.3 GenScript CXO Services Introduction
11.20.4 GenScript Revenue in CXO Services Business (2020-2025)
11.20.5 GenScript Recent Development
11.21 ProBioGen
11.21.1 ProBioGen Company Details
11.21.2 ProBioGen Business Overview
11.21.3 ProBioGen CXO Services Introduction
11.21.4 ProBioGen Revenue in CXO Services Business (2020-2025)
11.21.5 ProBioGen Recent Development
11.22 Northway Biotech
11.22.1 Northway Biotech Company Details
11.22.2 Northway Biotech Business Overview
11.22.3 Northway Biotech CXO Services Introduction
11.22.4 Northway Biotech Revenue in CXO Services Business (2020-2025)
11.22.5 Northway Biotech Recent Development
11.23 3P Biopharmaceuticals
11.23.1 3P Biopharmaceuticals Company Details
11.23.2 3P Biopharmaceuticals Business Overview
11.23.3 3P Biopharmaceuticals CXO Services Introduction
11.23.4 3P Biopharmaceuticals Revenue in CXO Services Business (2020-2025)
11.23.5 3P Biopharmaceuticals Recent Development
11.24 Inotiv
11.24.1 Inotiv Company Details
11.24.2 Inotiv Business Overview
11.24.3 Inotiv CXO Services Introduction
11.24.4 Inotiv Revenue in CXO Services Business (2020-2025)
11.24.5 Inotiv Recent Development
11.25 ChemPartner
11.25.1 ChemPartner Company Details
11.25.2 ChemPartner Business Overview
11.25.3 ChemPartner CXO Services Introduction
11.25.4 ChemPartner Revenue in CXO Services Business (2020-2025)
11.25.5 ChemPartner Recent Development
11.26 JOINN Lab
11.26.1 JOINN Lab Company Details
11.26.2 JOINN Lab Business Overview
11.26.3 JOINN Lab CXO Services Introduction
11.26.4 JOINN Lab Revenue in CXO Services Business (2020-2025)
11.26.5 JOINN Lab Recent Development
11.27 EVOTEC
11.27.1 EVOTEC Company Details
11.27.2 EVOTEC Business Overview
11.27.3 EVOTEC CXO Services Introduction
11.27.4 EVOTEC Revenue in CXO Services Business (2020-2025)
11.27.5 EVOTEC Recent Development
11.28 Medicilon
11.28.1 Medicilon Company Details
11.28.2 Medicilon Business Overview
11.28.3 Medicilon CXO Services Introduction
11.28.4 Medicilon Revenue in CXO Services Business (2020-2025)
11.28.5 Medicilon Recent Development
11.29 Crown Bioscience
11.29.1 Crown Bioscience Company Details
11.29.2 Crown Bioscience Business Overview
11.29.3 Crown Bioscience CXO Services Introduction
11.29.4 Crown Bioscience Revenue in CXO Services Business (2020-2025)
11.29.5 Crown Bioscience Recent Development
11.30 Champion Oncology
11.30.1 Champion Oncology Company Details
11.30.2 Champion Oncology Business Overview
11.30.3 Champion Oncology CXO Services Introduction
11.30.4 Champion Oncology Revenue in CXO Services Business (2020-2025)
11.30.5 Champion Oncology Recent Development
11.31 IQVIA
11.31.1 IQVIA Company Details
11.31.2 IQVIA Business Overview
11.31.3 IQVIA CXO Services Introduction
11.31.4 IQVIA Revenue in CXO Services Business (2020-2025)
11.31.5 IQVIA Recent Development
11.32 Parexel
11.32.1 Parexel Company Details
11.32.2 Parexel Business Overview
11.32.3 Parexel CXO Services Introduction
11.32.4 Parexel Revenue in CXO Services Business (2020-2025)
11.32.5 Parexel Recent Development
11.33 Syneos Health
11.33.1 Syneos Health Company Details
11.33.2 Syneos Health Business Overview
11.33.3 Syneos Health CXO Services Introduction
11.33.4 Syneos Health Revenue in CXO Services Business (2020-2025)
11.33.5 Syneos Health Recent Development
11.34 PRA Health Sciences
11.34.1 PRA Health Sciences Company Details
11.34.2 PRA Health Sciences Business Overview
11.34.3 PRA Health Sciences CXO Services Introduction
11.34.4 PRA Health Sciences Revenue in CXO Services Business (2020-2025)
11.34.5 PRA Health Sciences Recent Development
11.35 Medpace Holdings
11.35.1 Medpace Holdings Company Details
11.35.2 Medpace Holdings Business Overview
11.35.3 Medpace Holdings CXO Services Introduction
11.35.4 Medpace Holdings Revenue in CXO Services Business (2020-2025)
11.35.5 Medpace Holdings Recent Development
11.36 Tigermed
11.36.1 Tigermed Company Details
11.36.2 Tigermed Business Overview
11.36.3 Tigermed CXO Services Introduction
11.36.4 Tigermed Revenue in CXO Services Business (2020-2025)
11.36.5 Tigermed Recent Development
11.37 Boji Medical Technology
11.37.1 Boji Medical Technology Company Details
11.37.2 Boji Medical Technology Business Overview
11.37.3 Boji Medical Technology CXO Services Introduction
11.37.4 Boji Medical Technology Revenue in CXO Services Business (2020-2025)
11.37.5 Boji Medical Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CXO Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 CRO
1.2.3 CDMO
1.3 Market by Application
1.3.1 Global CXO Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Companies
1.3.3 Medical Device Companies
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CXO Services Market Perspective (2020-2031)
2.2 Global CXO Services Growth Trends by Region
2.2.1 Global CXO Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CXO Services Historic Market Size by Region (2020-2025)
2.2.3 CXO Services Forecasted Market Size by Region (2026-2031)
2.3 CXO Services Market Dynamics
2.3.1 CXO Services Industry Trends
2.3.2 CXO Services Market Drivers
2.3.3 CXO Services Market Challenges
2.3.4 CXO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CXO Services Players by Revenue
3.1.1 Global Top CXO Services Players by Revenue (2020-2025)
3.1.2 Global CXO Services Revenue Market Share by Players (2020-2025)
3.2 Global Top CXO Services Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CXO Services Revenue
3.4 Global CXO Services Market Concentration Ratio
3.4.1 Global CXO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CXO Services Revenue in 2024
3.5 Global Key Players of CXO Services Head office and Area Served
3.6 Global Key Players of CXO Services, Product and Application
3.7 Global Key Players of CXO Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CXO Services Breakdown Data by Type
4.1 Global CXO Services Historic Market Size by Type (2020-2025)
4.2 Global CXO Services Forecasted Market Size by Type (2026-2031)
5 CXO Services Breakdown Data by Application
5.1 Global CXO Services Historic Market Size by Application (2020-2025)
5.2 Global CXO Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CXO Services Market Size (2020-2031)
6.2 North America CXO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CXO Services Market Size by Country (2020-2025)
6.4 North America CXO Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CXO Services Market Size (2020-2031)
7.2 Europe CXO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CXO Services Market Size by Country (2020-2025)
7.4 Europe CXO Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific CXO Services Market Size (2020-2031)
8.2 Asia-Pacific CXO Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CXO Services Market Size by Region (2020-2025)
8.4 Asia-Pacific CXO Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America CXO Services Market Size (2020-2031)
9.2 Latin America CXO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CXO Services Market Size by Country (2020-2025)
9.4 Latin America CXO Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CXO Services Market Size (2020-2031)
10.2 Middle East & Africa CXO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CXO Services Market Size by Country (2020-2025)
10.4 Middle East & Africa CXO Services Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza CXO Services Introduction
11.1.4 Lonza Revenue in CXO Services Business (2020-2025)
11.1.5 Lonza Recent Development
11.2 Catalent
11.2.1 Catalent Company Details
11.2.2 Catalent Business Overview
11.2.3 Catalent CXO Services Introduction
11.2.4 Catalent Revenue in CXO Services Business (2020-2025)
11.2.5 Catalent Recent Development
11.3 Samsung Biologics
11.3.1 Samsung Biologics Company Details
11.3.2 Samsung Biologics Business Overview
11.3.3 Samsung Biologics CXO Services Introduction
11.3.4 Samsung Biologics Revenue in CXO Services Business (2020-2025)
11.3.5 Samsung Biologics Recent Development
11.4 FUJIFILM Diosynth Biotechnologies
11.4.1 FUJIFILM Diosynth Biotechnologies Company Details
11.4.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.4.3 FUJIFILM Diosynth Biotechnologies CXO Services Introduction
11.4.4 FUJIFILM Diosynth Biotechnologies Revenue in CXO Services Business (2020-2025)
11.4.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim CXO Services Introduction
11.5.4 Boehringer Ingelheim Revenue in CXO Services Business (2020-2025)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Wuxi AppTec
11.6.1 Wuxi AppTec Company Details
11.6.2 Wuxi AppTec Business Overview
11.6.3 Wuxi AppTec CXO Services Introduction
11.6.4 Wuxi AppTec Revenue in CXO Services Business (2020-2025)
11.6.5 Wuxi AppTec Recent Development
11.7 Charles River
11.7.1 Charles River Company Details
11.7.2 Charles River Business Overview
11.7.3 Charles River CXO Services Introduction
11.7.4 Charles River Revenue in CXO Services Business (2020-2025)
11.7.5 Charles River Recent Development
11.8 Labcorp
11.8.1 Labcorp Company Details
11.8.2 Labcorp Business Overview
11.8.3 Labcorp CXO Services Introduction
11.8.4 Labcorp Revenue in CXO Services Business (2020-2025)
11.8.5 Labcorp Recent Development
11.9 Eurofins Scientific
11.9.1 Eurofins Scientific Company Details
11.9.2 Eurofins Scientific Business Overview
11.9.3 Eurofins Scientific CXO Services Introduction
11.9.4 Eurofins Scientific Revenue in CXO Services Business (2020-2025)
11.9.5 Eurofins Scientific Recent Development
11.10 PPD, Inc.
11.10.1 PPD, Inc. Company Details
11.10.2 PPD, Inc. Business Overview
11.10.3 PPD, Inc. CXO Services Introduction
11.10.4 PPD, Inc. Revenue in CXO Services Business (2020-2025)
11.10.5 PPD, Inc. Recent Development
11.11 ICON Plc.
11.11.1 ICON Plc. Company Details
11.11.2 ICON Plc. Business Overview
11.11.3 ICON Plc. CXO Services Introduction
11.11.4 ICON Plc. Revenue in CXO Services Business (2020-2025)
11.11.5 ICON Plc. Recent Development
11.12 Pharmaron
11.12.1 Pharmaron Company Details
11.12.2 Pharmaron Business Overview
11.12.3 Pharmaron CXO Services Introduction
11.12.4 Pharmaron Revenue in CXO Services Business (2020-2025)
11.12.5 Pharmaron Recent Development
11.13 Recipharm
11.13.1 Recipharm Company Details
11.13.2 Recipharm Business Overview
11.13.3 Recipharm CXO Services Introduction
11.13.4 Recipharm Revenue in CXO Services Business (2020-2025)
11.13.5 Recipharm Recent Development
11.14 Thermo Fisher Scientific
11.14.1 Thermo Fisher Scientific Company Details
11.14.2 Thermo Fisher Scientific Business Overview
11.14.3 Thermo Fisher Scientific CXO Services Introduction
11.14.4 Thermo Fisher Scientific Revenue in CXO Services Business (2020-2025)
11.14.5 Thermo Fisher Scientific Recent Development
11.15 AGC Biologics
11.15.1 AGC Biologics Company Details
11.15.2 AGC Biologics Business Overview
11.15.3 AGC Biologics CXO Services Introduction
11.15.4 AGC Biologics Revenue in CXO Services Business (2020-2025)
11.15.5 AGC Biologics Recent Development
11.16 Rentschler Biopharma
11.16.1 Rentschler Biopharma Company Details
11.16.2 Rentschler Biopharma Business Overview
11.16.3 Rentschler Biopharma CXO Services Introduction
11.16.4 Rentschler Biopharma Revenue in CXO Services Business (2020-2025)
11.16.5 Rentschler Biopharma Recent Development
11.17 KBI Biopharma
11.17.1 KBI Biopharma Company Details
11.17.2 KBI Biopharma Business Overview
11.17.3 KBI Biopharma CXO Services Introduction
11.17.4 KBI Biopharma Revenue in CXO Services Business (2020-2025)
11.17.5 KBI Biopharma Recent Development
11.18 Siegfried
11.18.1 Siegfried Company Details
11.18.2 Siegfried Business Overview
11.18.3 Siegfried CXO Services Introduction
11.18.4 Siegfried Revenue in CXO Services Business (2020-2025)
11.18.5 Siegfried Recent Development
11.19 Aenova Group
11.19.1 Aenova Group Company Details
11.19.2 Aenova Group Business Overview
11.19.3 Aenova Group CXO Services Introduction
11.19.4 Aenova Group Revenue in CXO Services Business (2020-2025)
11.19.5 Aenova Group Recent Development
11.20 GenScript
11.20.1 GenScript Company Details
11.20.2 GenScript Business Overview
11.20.3 GenScript CXO Services Introduction
11.20.4 GenScript Revenue in CXO Services Business (2020-2025)
11.20.5 GenScript Recent Development
11.21 ProBioGen
11.21.1 ProBioGen Company Details
11.21.2 ProBioGen Business Overview
11.21.3 ProBioGen CXO Services Introduction
11.21.4 ProBioGen Revenue in CXO Services Business (2020-2025)
11.21.5 ProBioGen Recent Development
11.22 Northway Biotech
11.22.1 Northway Biotech Company Details
11.22.2 Northway Biotech Business Overview
11.22.3 Northway Biotech CXO Services Introduction
11.22.4 Northway Biotech Revenue in CXO Services Business (2020-2025)
11.22.5 Northway Biotech Recent Development
11.23 3P Biopharmaceuticals
11.23.1 3P Biopharmaceuticals Company Details
11.23.2 3P Biopharmaceuticals Business Overview
11.23.3 3P Biopharmaceuticals CXO Services Introduction
11.23.4 3P Biopharmaceuticals Revenue in CXO Services Business (2020-2025)
11.23.5 3P Biopharmaceuticals Recent Development
11.24 Inotiv
11.24.1 Inotiv Company Details
11.24.2 Inotiv Business Overview
11.24.3 Inotiv CXO Services Introduction
11.24.4 Inotiv Revenue in CXO Services Business (2020-2025)
11.24.5 Inotiv Recent Development
11.25 ChemPartner
11.25.1 ChemPartner Company Details
11.25.2 ChemPartner Business Overview
11.25.3 ChemPartner CXO Services Introduction
11.25.4 ChemPartner Revenue in CXO Services Business (2020-2025)
11.25.5 ChemPartner Recent Development
11.26 JOINN Lab
11.26.1 JOINN Lab Company Details
11.26.2 JOINN Lab Business Overview
11.26.3 JOINN Lab CXO Services Introduction
11.26.4 JOINN Lab Revenue in CXO Services Business (2020-2025)
11.26.5 JOINN Lab Recent Development
11.27 EVOTEC
11.27.1 EVOTEC Company Details
11.27.2 EVOTEC Business Overview
11.27.3 EVOTEC CXO Services Introduction
11.27.4 EVOTEC Revenue in CXO Services Business (2020-2025)
11.27.5 EVOTEC Recent Development
11.28 Medicilon
11.28.1 Medicilon Company Details
11.28.2 Medicilon Business Overview
11.28.3 Medicilon CXO Services Introduction
11.28.4 Medicilon Revenue in CXO Services Business (2020-2025)
11.28.5 Medicilon Recent Development
11.29 Crown Bioscience
11.29.1 Crown Bioscience Company Details
11.29.2 Crown Bioscience Business Overview
11.29.3 Crown Bioscience CXO Services Introduction
11.29.4 Crown Bioscience Revenue in CXO Services Business (2020-2025)
11.29.5 Crown Bioscience Recent Development
11.30 Champion Oncology
11.30.1 Champion Oncology Company Details
11.30.2 Champion Oncology Business Overview
11.30.3 Champion Oncology CXO Services Introduction
11.30.4 Champion Oncology Revenue in CXO Services Business (2020-2025)
11.30.5 Champion Oncology Recent Development
11.31 IQVIA
11.31.1 IQVIA Company Details
11.31.2 IQVIA Business Overview
11.31.3 IQVIA CXO Services Introduction
11.31.4 IQVIA Revenue in CXO Services Business (2020-2025)
11.31.5 IQVIA Recent Development
11.32 Parexel
11.32.1 Parexel Company Details
11.32.2 Parexel Business Overview
11.32.3 Parexel CXO Services Introduction
11.32.4 Parexel Revenue in CXO Services Business (2020-2025)
11.32.5 Parexel Recent Development
11.33 Syneos Health
11.33.1 Syneos Health Company Details
11.33.2 Syneos Health Business Overview
11.33.3 Syneos Health CXO Services Introduction
11.33.4 Syneos Health Revenue in CXO Services Business (2020-2025)
11.33.5 Syneos Health Recent Development
11.34 PRA Health Sciences
11.34.1 PRA Health Sciences Company Details
11.34.2 PRA Health Sciences Business Overview
11.34.3 PRA Health Sciences CXO Services Introduction
11.34.4 PRA Health Sciences Revenue in CXO Services Business (2020-2025)
11.34.5 PRA Health Sciences Recent Development
11.35 Medpace Holdings
11.35.1 Medpace Holdings Company Details
11.35.2 Medpace Holdings Business Overview
11.35.3 Medpace Holdings CXO Services Introduction
11.35.4 Medpace Holdings Revenue in CXO Services Business (2020-2025)
11.35.5 Medpace Holdings Recent Development
11.36 Tigermed
11.36.1 Tigermed Company Details
11.36.2 Tigermed Business Overview
11.36.3 Tigermed CXO Services Introduction
11.36.4 Tigermed Revenue in CXO Services Business (2020-2025)
11.36.5 Tigermed Recent Development
11.37 Boji Medical Technology
11.37.1 Boji Medical Technology Company Details
11.37.2 Boji Medical Technology Business Overview
11.37.3 Boji Medical Technology CXO Services Introduction
11.37.4 Boji Medical Technology Revenue in CXO Services Business (2020-2025)
11.37.5 Boji Medical Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global CXO Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of CRO
Table 3. Key Players of CDMO
Table 4. Global CXO Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global CXO Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global CXO Services Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global CXO Services Market Share by Region (2020-2025)
Table 8. Global CXO Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global CXO Services Market Share by Region (2026-2031)
Table 10. CXO Services Market Trends
Table 11. CXO Services Market Drivers
Table 12. CXO Services Market Challenges
Table 13. CXO Services Market Restraints
Table 14. Global CXO Services Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global CXO Services Market Share by Players (2020-2025)
Table 16. Global Top CXO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CXO Services as of 2024)
Table 17. Ranking of Global Top CXO Services Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by CXO Services Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of CXO Services, Headquarters and Area Served
Table 20. Global Key Players of CXO Services, Product and Application
Table 21. Global Key Players of CXO Services, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CXO Services Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global CXO Services Revenue Market Share by Type (2020-2025)
Table 25. Global CXO Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global CXO Services Revenue Market Share by Type (2026-2031)
Table 27. Global CXO Services Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global CXO Services Revenue Market Share by Application (2020-2025)
Table 29. Global CXO Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global CXO Services Revenue Market Share by Application (2026-2031)
Table 31. North America CXO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America CXO Services Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America CXO Services Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe CXO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe CXO Services Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe CXO Services Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific CXO Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific CXO Services Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific CXO Services Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America CXO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America CXO Services Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America CXO Services Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa CXO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa CXO Services Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa CXO Services Market Size by Country (2026-2031) & (US$ Million)
Table 46. Lonza Company Details
Table 47. Lonza Business Overview
Table 48. Lonza CXO Services Product
Table 49. Lonza Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 50. Lonza Recent Development
Table 51. Catalent Company Details
Table 52. Catalent Business Overview
Table 53. Catalent CXO Services Product
Table 54. Catalent Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 55. Catalent Recent Development
Table 56. Samsung Biologics Company Details
Table 57. Samsung Biologics Business Overview
Table 58. Samsung Biologics CXO Services Product
Table 59. Samsung Biologics Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 60. Samsung Biologics Recent Development
Table 61. FUJIFILM Diosynth Biotechnologies Company Details
Table 62. FUJIFILM Diosynth Biotechnologies Business Overview
Table 63. FUJIFILM Diosynth Biotechnologies CXO Services Product
Table 64. FUJIFILM Diosynth Biotechnologies Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 65. FUJIFILM Diosynth Biotechnologies Recent Development
Table 66. Boehringer Ingelheim Company Details
Table 67. Boehringer Ingelheim Business Overview
Table 68. Boehringer Ingelheim CXO Services Product
Table 69. Boehringer Ingelheim Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 70. Boehringer Ingelheim Recent Development
Table 71. Wuxi AppTec Company Details
Table 72. Wuxi AppTec Business Overview
Table 73. Wuxi AppTec CXO Services Product
Table 74. Wuxi AppTec Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 75. Wuxi AppTec Recent Development
Table 76. Charles River Company Details
Table 77. Charles River Business Overview
Table 78. Charles River CXO Services Product
Table 79. Charles River Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 80. Charles River Recent Development
Table 81. Labcorp Company Details
Table 82. Labcorp Business Overview
Table 83. Labcorp CXO Services Product
Table 84. Labcorp Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 85. Labcorp Recent Development
Table 86. Eurofins Scientific Company Details
Table 87. Eurofins Scientific Business Overview
Table 88. Eurofins Scientific CXO Services Product
Table 89. Eurofins Scientific Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 90. Eurofins Scientific Recent Development
Table 91. PPD, Inc. Company Details
Table 92. PPD, Inc. Business Overview
Table 93. PPD, Inc. CXO Services Product
Table 94. PPD, Inc. Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 95. PPD, Inc. Recent Development
Table 96. ICON Plc. Company Details
Table 97. ICON Plc. Business Overview
Table 98. ICON Plc. CXO Services Product
Table 99. ICON Plc. Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 100. ICON Plc. Recent Development
Table 101. Pharmaron Company Details
Table 102. Pharmaron Business Overview
Table 103. Pharmaron CXO Services Product
Table 104. Pharmaron Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 105. Pharmaron Recent Development
Table 106. Recipharm Company Details
Table 107. Recipharm Business Overview
Table 108. Recipharm CXO Services Product
Table 109. Recipharm Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 110. Recipharm Recent Development
Table 111. Thermo Fisher Scientific Company Details
Table 112. Thermo Fisher Scientific Business Overview
Table 113. Thermo Fisher Scientific CXO Services Product
Table 114. Thermo Fisher Scientific Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 115. Thermo Fisher Scientific Recent Development
Table 116. AGC Biologics Company Details
Table 117. AGC Biologics Business Overview
Table 118. AGC Biologics CXO Services Product
Table 119. AGC Biologics Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 120. AGC Biologics Recent Development
Table 121. Rentschler Biopharma Company Details
Table 122. Rentschler Biopharma Business Overview
Table 123. Rentschler Biopharma CXO Services Product
Table 124. Rentschler Biopharma Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 125. Rentschler Biopharma Recent Development
Table 126. KBI Biopharma Company Details
Table 127. KBI Biopharma Business Overview
Table 128. KBI Biopharma CXO Services Product
Table 129. KBI Biopharma Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 130. KBI Biopharma Recent Development
Table 131. Siegfried Company Details
Table 132. Siegfried Business Overview
Table 133. Siegfried CXO Services Product
Table 134. Siegfried Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 135. Siegfried Recent Development
Table 136. Aenova Group Company Details
Table 137. Aenova Group Business Overview
Table 138. Aenova Group CXO Services Product
Table 139. Aenova Group Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 140. Aenova Group Recent Development
Table 141. GenScript Company Details
Table 142. GenScript Business Overview
Table 143. GenScript CXO Services Product
Table 144. GenScript Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 145. GenScript Recent Development
Table 146. ProBioGen Company Details
Table 147. ProBioGen Business Overview
Table 148. ProBioGen CXO Services Product
Table 149. ProBioGen Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 150. ProBioGen Recent Development
Table 151. Northway Biotech Company Details
Table 152. Northway Biotech Business Overview
Table 153. Northway Biotech CXO Services Product
Table 154. Northway Biotech Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 155. Northway Biotech Recent Development
Table 156. 3P Biopharmaceuticals Company Details
Table 157. 3P Biopharmaceuticals Business Overview
Table 158. 3P Biopharmaceuticals CXO Services Product
Table 159. 3P Biopharmaceuticals Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 160. 3P Biopharmaceuticals Recent Development
Table 161. Inotiv Company Details
Table 162. Inotiv Business Overview
Table 163. Inotiv CXO Services Product
Table 164. Inotiv Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 165. Inotiv Recent Development
Table 166. ChemPartner Company Details
Table 167. ChemPartner Business Overview
Table 168. ChemPartner CXO Services Product
Table 169. ChemPartner Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 170. ChemPartner Recent Development
Table 171. JOINN Lab Company Details
Table 172. JOINN Lab Business Overview
Table 173. JOINN Lab CXO Services Product
Table 174. JOINN Lab Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 175. JOINN Lab Recent Development
Table 176. EVOTEC Company Details
Table 177. EVOTEC Business Overview
Table 178. EVOTEC CXO Services Product
Table 179. EVOTEC Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 180. EVOTEC Recent Development
Table 181. Medicilon Company Details
Table 182. Medicilon Business Overview
Table 183. Medicilon CXO Services Product
Table 184. Medicilon Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 185. Medicilon Recent Development
Table 186. Crown Bioscience Company Details
Table 187. Crown Bioscience Business Overview
Table 188. Crown Bioscience CXO Services Product
Table 189. Crown Bioscience Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 190. Crown Bioscience Recent Development
Table 191. Champion Oncology Company Details
Table 192. Champion Oncology Business Overview
Table 193. Champion Oncology CXO Services Product
Table 194. Champion Oncology Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 195. Champion Oncology Recent Development
Table 196. IQVIA Company Details
Table 197. IQVIA Business Overview
Table 198. IQVIA CXO Services Product
Table 199. IQVIA Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 200. IQVIA Recent Development
Table 201. Parexel Company Details
Table 202. Parexel Business Overview
Table 203. Parexel CXO Services Product
Table 204. Parexel Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 205. Parexel Recent Development
Table 206. Syneos Health Company Details
Table 207. Syneos Health Business Overview
Table 208. Syneos Health CXO Services Product
Table 209. Syneos Health Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 210. Syneos Health Recent Development
Table 211. PRA Health Sciences Company Details
Table 212. PRA Health Sciences Business Overview
Table 213. PRA Health Sciences CXO Services Product
Table 214. PRA Health Sciences Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 215. PRA Health Sciences Recent Development
Table 216. Medpace Holdings Company Details
Table 217. Medpace Holdings Business Overview
Table 218. Medpace Holdings CXO Services Product
Table 219. Medpace Holdings Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 220. Medpace Holdings Recent Development
Table 221. Tigermed Company Details
Table 222. Tigermed Business Overview
Table 223. Tigermed CXO Services Product
Table 224. Tigermed Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 225. Tigermed Recent Development
Table 226. Boji Medical Technology Company Details
Table 227. Boji Medical Technology Business Overview
Table 228. Boji Medical Technology CXO Services Product
Table 229. Boji Medical Technology Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 230. Boji Medical Technology Recent Development
Table 231. Research Programs/Design for This Report
Table 232. Key Data Information from Secondary Sources
Table 233. Key Data Information from Primary Sources
Table 234. Authors List of This Report
List of Figures
Figure 1. CXO Services Picture
Figure 2. Global CXO Services Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CXO Services Market Share by Type: 2024 VS 2031
Figure 4. CRO Features
Figure 5. CDMO Features
Figure 6. Global CXO Services Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global CXO Services Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. Medical Device Companies Case Studies
Figure 10. Other Case Studies
Figure 11. CXO Services Report Years Considered
Figure 12. Global CXO Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global CXO Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global CXO Services Market Share by Region: 2024 VS 2031
Figure 15. Global CXO Services Market Share by Players in 2024
Figure 16. Global CXO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by CXO Services Revenue in 2024
Figure 18. North America CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America CXO Services Market Share by Country (2020-2031)
Figure 20. United States CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe CXO Services Market Share by Country (2020-2031)
Figure 24. Germany CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Ireland CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific CXO Services Market Share by Region (2020-2031)
Figure 32. China CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia & New Zealand CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America CXO Services Market Share by Country (2020-2031)
Figure 40. Mexico CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa CXO Services Market Share by Country (2020-2031)
Figure 44. Israel CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Lonza Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 48. Catalent Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 49. Samsung Biologics Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 50. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 51. Boehringer Ingelheim Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 52. Wuxi AppTec Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 53. Charles River Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 54. Labcorp Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 55. Eurofins Scientific Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 56. PPD, Inc. Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 57. ICON Plc. Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 58. Pharmaron Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 59. Recipharm Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 60. Thermo Fisher Scientific Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 61. AGC Biologics Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 62. Rentschler Biopharma Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 63. KBI Biopharma Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 64. Siegfried Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 65. Aenova Group Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 66. GenScript Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 67. ProBioGen Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 68. Northway Biotech Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 69. 3P Biopharmaceuticals Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 70. Inotiv Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 71. ChemPartner Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 72. JOINN Lab Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 73. EVOTEC Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 74. Medicilon Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 75. Crown Bioscience Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 76. Champion Oncology Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 77. IQVIA Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 78. Parexel Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 79. Syneos Health Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 80. PRA Health Sciences Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 81. Medpace Holdings Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 82. Tigermed Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 83. Boji Medical Technology Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed
Table 1. Global CXO Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of CRO
Table 3. Key Players of CDMO
Table 4. Global CXO Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global CXO Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global CXO Services Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global CXO Services Market Share by Region (2020-2025)
Table 8. Global CXO Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global CXO Services Market Share by Region (2026-2031)
Table 10. CXO Services Market Trends
Table 11. CXO Services Market Drivers
Table 12. CXO Services Market Challenges
Table 13. CXO Services Market Restraints
Table 14. Global CXO Services Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global CXO Services Market Share by Players (2020-2025)
Table 16. Global Top CXO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CXO Services as of 2024)
Table 17. Ranking of Global Top CXO Services Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by CXO Services Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of CXO Services, Headquarters and Area Served
Table 20. Global Key Players of CXO Services, Product and Application
Table 21. Global Key Players of CXO Services, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CXO Services Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global CXO Services Revenue Market Share by Type (2020-2025)
Table 25. Global CXO Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global CXO Services Revenue Market Share by Type (2026-2031)
Table 27. Global CXO Services Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global CXO Services Revenue Market Share by Application (2020-2025)
Table 29. Global CXO Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global CXO Services Revenue Market Share by Application (2026-2031)
Table 31. North America CXO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America CXO Services Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America CXO Services Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe CXO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe CXO Services Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe CXO Services Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific CXO Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific CXO Services Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific CXO Services Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America CXO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America CXO Services Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America CXO Services Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa CXO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa CXO Services Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa CXO Services Market Size by Country (2026-2031) & (US$ Million)
Table 46. Lonza Company Details
Table 47. Lonza Business Overview
Table 48. Lonza CXO Services Product
Table 49. Lonza Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 50. Lonza Recent Development
Table 51. Catalent Company Details
Table 52. Catalent Business Overview
Table 53. Catalent CXO Services Product
Table 54. Catalent Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 55. Catalent Recent Development
Table 56. Samsung Biologics Company Details
Table 57. Samsung Biologics Business Overview
Table 58. Samsung Biologics CXO Services Product
Table 59. Samsung Biologics Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 60. Samsung Biologics Recent Development
Table 61. FUJIFILM Diosynth Biotechnologies Company Details
Table 62. FUJIFILM Diosynth Biotechnologies Business Overview
Table 63. FUJIFILM Diosynth Biotechnologies CXO Services Product
Table 64. FUJIFILM Diosynth Biotechnologies Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 65. FUJIFILM Diosynth Biotechnologies Recent Development
Table 66. Boehringer Ingelheim Company Details
Table 67. Boehringer Ingelheim Business Overview
Table 68. Boehringer Ingelheim CXO Services Product
Table 69. Boehringer Ingelheim Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 70. Boehringer Ingelheim Recent Development
Table 71. Wuxi AppTec Company Details
Table 72. Wuxi AppTec Business Overview
Table 73. Wuxi AppTec CXO Services Product
Table 74. Wuxi AppTec Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 75. Wuxi AppTec Recent Development
Table 76. Charles River Company Details
Table 77. Charles River Business Overview
Table 78. Charles River CXO Services Product
Table 79. Charles River Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 80. Charles River Recent Development
Table 81. Labcorp Company Details
Table 82. Labcorp Business Overview
Table 83. Labcorp CXO Services Product
Table 84. Labcorp Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 85. Labcorp Recent Development
Table 86. Eurofins Scientific Company Details
Table 87. Eurofins Scientific Business Overview
Table 88. Eurofins Scientific CXO Services Product
Table 89. Eurofins Scientific Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 90. Eurofins Scientific Recent Development
Table 91. PPD, Inc. Company Details
Table 92. PPD, Inc. Business Overview
Table 93. PPD, Inc. CXO Services Product
Table 94. PPD, Inc. Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 95. PPD, Inc. Recent Development
Table 96. ICON Plc. Company Details
Table 97. ICON Plc. Business Overview
Table 98. ICON Plc. CXO Services Product
Table 99. ICON Plc. Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 100. ICON Plc. Recent Development
Table 101. Pharmaron Company Details
Table 102. Pharmaron Business Overview
Table 103. Pharmaron CXO Services Product
Table 104. Pharmaron Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 105. Pharmaron Recent Development
Table 106. Recipharm Company Details
Table 107. Recipharm Business Overview
Table 108. Recipharm CXO Services Product
Table 109. Recipharm Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 110. Recipharm Recent Development
Table 111. Thermo Fisher Scientific Company Details
Table 112. Thermo Fisher Scientific Business Overview
Table 113. Thermo Fisher Scientific CXO Services Product
Table 114. Thermo Fisher Scientific Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 115. Thermo Fisher Scientific Recent Development
Table 116. AGC Biologics Company Details
Table 117. AGC Biologics Business Overview
Table 118. AGC Biologics CXO Services Product
Table 119. AGC Biologics Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 120. AGC Biologics Recent Development
Table 121. Rentschler Biopharma Company Details
Table 122. Rentschler Biopharma Business Overview
Table 123. Rentschler Biopharma CXO Services Product
Table 124. Rentschler Biopharma Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 125. Rentschler Biopharma Recent Development
Table 126. KBI Biopharma Company Details
Table 127. KBI Biopharma Business Overview
Table 128. KBI Biopharma CXO Services Product
Table 129. KBI Biopharma Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 130. KBI Biopharma Recent Development
Table 131. Siegfried Company Details
Table 132. Siegfried Business Overview
Table 133. Siegfried CXO Services Product
Table 134. Siegfried Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 135. Siegfried Recent Development
Table 136. Aenova Group Company Details
Table 137. Aenova Group Business Overview
Table 138. Aenova Group CXO Services Product
Table 139. Aenova Group Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 140. Aenova Group Recent Development
Table 141. GenScript Company Details
Table 142. GenScript Business Overview
Table 143. GenScript CXO Services Product
Table 144. GenScript Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 145. GenScript Recent Development
Table 146. ProBioGen Company Details
Table 147. ProBioGen Business Overview
Table 148. ProBioGen CXO Services Product
Table 149. ProBioGen Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 150. ProBioGen Recent Development
Table 151. Northway Biotech Company Details
Table 152. Northway Biotech Business Overview
Table 153. Northway Biotech CXO Services Product
Table 154. Northway Biotech Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 155. Northway Biotech Recent Development
Table 156. 3P Biopharmaceuticals Company Details
Table 157. 3P Biopharmaceuticals Business Overview
Table 158. 3P Biopharmaceuticals CXO Services Product
Table 159. 3P Biopharmaceuticals Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 160. 3P Biopharmaceuticals Recent Development
Table 161. Inotiv Company Details
Table 162. Inotiv Business Overview
Table 163. Inotiv CXO Services Product
Table 164. Inotiv Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 165. Inotiv Recent Development
Table 166. ChemPartner Company Details
Table 167. ChemPartner Business Overview
Table 168. ChemPartner CXO Services Product
Table 169. ChemPartner Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 170. ChemPartner Recent Development
Table 171. JOINN Lab Company Details
Table 172. JOINN Lab Business Overview
Table 173. JOINN Lab CXO Services Product
Table 174. JOINN Lab Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 175. JOINN Lab Recent Development
Table 176. EVOTEC Company Details
Table 177. EVOTEC Business Overview
Table 178. EVOTEC CXO Services Product
Table 179. EVOTEC Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 180. EVOTEC Recent Development
Table 181. Medicilon Company Details
Table 182. Medicilon Business Overview
Table 183. Medicilon CXO Services Product
Table 184. Medicilon Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 185. Medicilon Recent Development
Table 186. Crown Bioscience Company Details
Table 187. Crown Bioscience Business Overview
Table 188. Crown Bioscience CXO Services Product
Table 189. Crown Bioscience Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 190. Crown Bioscience Recent Development
Table 191. Champion Oncology Company Details
Table 192. Champion Oncology Business Overview
Table 193. Champion Oncology CXO Services Product
Table 194. Champion Oncology Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 195. Champion Oncology Recent Development
Table 196. IQVIA Company Details
Table 197. IQVIA Business Overview
Table 198. IQVIA CXO Services Product
Table 199. IQVIA Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 200. IQVIA Recent Development
Table 201. Parexel Company Details
Table 202. Parexel Business Overview
Table 203. Parexel CXO Services Product
Table 204. Parexel Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 205. Parexel Recent Development
Table 206. Syneos Health Company Details
Table 207. Syneos Health Business Overview
Table 208. Syneos Health CXO Services Product
Table 209. Syneos Health Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 210. Syneos Health Recent Development
Table 211. PRA Health Sciences Company Details
Table 212. PRA Health Sciences Business Overview
Table 213. PRA Health Sciences CXO Services Product
Table 214. PRA Health Sciences Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 215. PRA Health Sciences Recent Development
Table 216. Medpace Holdings Company Details
Table 217. Medpace Holdings Business Overview
Table 218. Medpace Holdings CXO Services Product
Table 219. Medpace Holdings Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 220. Medpace Holdings Recent Development
Table 221. Tigermed Company Details
Table 222. Tigermed Business Overview
Table 223. Tigermed CXO Services Product
Table 224. Tigermed Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 225. Tigermed Recent Development
Table 226. Boji Medical Technology Company Details
Table 227. Boji Medical Technology Business Overview
Table 228. Boji Medical Technology CXO Services Product
Table 229. Boji Medical Technology Revenue in CXO Services Business (2020-2025) & (US$ Million)
Table 230. Boji Medical Technology Recent Development
Table 231. Research Programs/Design for This Report
Table 232. Key Data Information from Secondary Sources
Table 233. Key Data Information from Primary Sources
Table 234. Authors List of This Report
List of Figures
Figure 1. CXO Services Picture
Figure 2. Global CXO Services Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CXO Services Market Share by Type: 2024 VS 2031
Figure 4. CRO Features
Figure 5. CDMO Features
Figure 6. Global CXO Services Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global CXO Services Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. Medical Device Companies Case Studies
Figure 10. Other Case Studies
Figure 11. CXO Services Report Years Considered
Figure 12. Global CXO Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global CXO Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global CXO Services Market Share by Region: 2024 VS 2031
Figure 15. Global CXO Services Market Share by Players in 2024
Figure 16. Global CXO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by CXO Services Revenue in 2024
Figure 18. North America CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America CXO Services Market Share by Country (2020-2031)
Figure 20. United States CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe CXO Services Market Share by Country (2020-2031)
Figure 24. Germany CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Ireland CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific CXO Services Market Share by Region (2020-2031)
Figure 32. China CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia & New Zealand CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America CXO Services Market Share by Country (2020-2031)
Figure 40. Mexico CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa CXO Services Market Share by Country (2020-2031)
Figure 44. Israel CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE CXO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Lonza Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 48. Catalent Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 49. Samsung Biologics Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 50. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 51. Boehringer Ingelheim Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 52. Wuxi AppTec Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 53. Charles River Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 54. Labcorp Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 55. Eurofins Scientific Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 56. PPD, Inc. Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 57. ICON Plc. Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 58. Pharmaron Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 59. Recipharm Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 60. Thermo Fisher Scientific Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 61. AGC Biologics Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 62. Rentschler Biopharma Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 63. KBI Biopharma Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 64. Siegfried Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 65. Aenova Group Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 66. GenScript Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 67. ProBioGen Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 68. Northway Biotech Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 69. 3P Biopharmaceuticals Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 70. Inotiv Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 71. ChemPartner Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 72. JOINN Lab Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 73. EVOTEC Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 74. Medicilon Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 75. Crown Bioscience Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 76. Champion Oncology Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 77. IQVIA Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 78. Parexel Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 79. Syneos Health Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 80. PRA Health Sciences Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 81. Medpace Holdings Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 82. Tigermed Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 83. Boji Medical Technology Revenue Growth Rate in CXO Services Business (2020-2025)
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Household Embroidery Machines Market Research Report 2025
Jul 18, 25
Global Residential Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Global Commercial Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232